[HTML][HTML] Safety and efficacy clinical trials for SYL1001, a novel short interfering RNA for the treatment of dry eye disease
JM Benitez-Del-Castillo… - … & visual science, 2016 - iovs.arvojournals.org
Purpose: To evaluate the efficacy and safety of SYL1001, a short interfering (si) RNA
targeting the transient receptor potential cation channel subfamily V member 1 (TRPV1), for …
targeting the transient receptor potential cation channel subfamily V member 1 (TRPV1), for …
[引用][C] Safety and efficacy clinical trials for SYL1001, a novel short interfering RNA for the treatment of dry eye disease
JM Benitez-Del-Castillo… - … and Visual Science, 2016 - portalcientifico.uah.es
[PDF][PDF] Safety and Efficacy Clinical Trials for SYL1001, a Novel Short Interfering RNA for the Treatment of Dry Eye
JM Benitez-Del-Castillo, J Moreno-Montanés… - pdfs.semanticscholar.org
PURPOSE. To evaluate the efficacy and safety of SYL1001, a short interfering (si) RNA
targeting the transient receptor potential cation channel subfamily V member 1 (TRPV1), for …
targeting the transient receptor potential cation channel subfamily V member 1 (TRPV1), for …
Safety and efficacy clinical trials for SYL1001, a novel short interfering RNA for the treatment of dry eye disease
JM Benitez-Del-Castillo… - … and Visual Science, 2016 - repositorio.uam.es
PURPOSE. To evaluate the efficacy and safety of SYL1001, a short interfering (si) RNA
targeting the transient receptor potential cation channel subfamily V member 1 (TRPV1), for …
targeting the transient receptor potential cation channel subfamily V member 1 (TRPV1), for …
[引用][C] Safety and Efficacy Clinical Trials for SYL1001, a Novel Short Interfering RNA for the Treatment of Dry Eye Disease
JM Benitez-Del-Castillo, J Moreno-Montañés… - … Opthalmology & Visual …, 2016 - cir.nii.ac.jp
Safety and Efficacy Clinical Trials for SYL1001, a Novel Short Interfering RNA for the
Treatment of Dry Eye Disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
Treatment of Dry Eye Disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
Safety and Efficacy Clinical Trials for SYL1001, a Novel Short Interfering RNA for the Treatment of Dry Eye Disease.
JM Benitez-Del-Castillo… - … & Visual Science, 2016 - europepmc.org
Purpose To evaluate the efficacy and safety of SYL1001, a short interfering (si) RNA
targeting the transient receptor potential cation channel subfamily V member 1 (TRPV1), for …
targeting the transient receptor potential cation channel subfamily V member 1 (TRPV1), for …
[HTML][HTML] Safety and Efficacy Clinical Trials for SYL1001, a Novel Short Interfering RNA for the Treatment of Dry Eye Disease
JM Benitez-Del-Castillo… - … & Visual Science, 2016 - tvst.arvojournals.org
Purpose: To evaluate the efficacy and safety of SYL1001, a short interfering (si) RNA
targeting the transient receptor potential cation channel subfamily V member 1 (TRPV1), for …
targeting the transient receptor potential cation channel subfamily V member 1 (TRPV1), for …
[引用][C] Safety and efficacy clinical trials for SYL1001, a novel short interfering RNA for the treatment of dry eye disease
JM Benitez-Del-Castillo… - Investigative …, 2016 - produccioncientifica.ucm.es
PURPOSE. To evaluate the efficacy and safety of SYL1001, a short interfering (si) RNA
targeting the transient receptor potential cation channel subfamily V member 1 (TRPV1), for …
targeting the transient receptor potential cation channel subfamily V member 1 (TRPV1), for …
Safety and Efficacy Clinical Trials for SYL1001, a Novel Short Interfering RNA for the Treatment of Dry Eye Disease
JM Benitez-Del-Castillo… - … & visual science, 2016 - pubmed.ncbi.nlm.nih.gov
Purpose To evaluate the efficacy and safety of SYL1001, a short interfering (si) RNA
targeting the transient receptor potential cation channel subfamily V member 1 (TRPV1), for …
targeting the transient receptor potential cation channel subfamily V member 1 (TRPV1), for …
[引用][C] Safety and efficacy clinical trials for SYL1001, a novel short interfering RNA for the treatment of dry eye disease
JM Benitez-Del-Castillo… - … and Visual Science, 2016 - portalcientifico.uah.es
PURPOSE. To evaluate the efficacy and safety of SYL1001, a short interfering (si) RNA
targeting the transient receptor potential cation channel subfamily V member 1 (TRPV1), for …
targeting the transient receptor potential cation channel subfamily V member 1 (TRPV1), for …